LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by relevance 2,440 pages found matching data breach- Glaxo gets Hit with another Paxil Birth Defects Lawsuit
Oct-17-06 Denver, CO Two years ago, little Eric Jackson was born with persistent pulmonary hypertension, a life-threatening lung disorder in which an infant's arteries to the lungs remain constricted after birth, limiting the amount of blood flow to the lungs and oxygen in the bloodstream. Persistent pulmonary hypertension (PPHN) is associated with substantial in... - Kaiser Kidney Program still causing Problems for Patients
Oct-15-06 San Francisco, CA Kaiser Permanente is coming under more fire for its error-plagued San Francisco kidney transplant program , despite patients being transferred to other hospitals. Kaiser announced May 12 that its kidney program was being shut down. Some patients waiting to be transferred to other programs died before the transfer could occur. Kaiser... - Ortho Evra Birth Control Patch - Statistics do not Lie
Oct-13-06 Dallas, TX During one 17-month period between April 2002 and September 2003, the FDA received 9,116 adverse reaction reports on the Ortho Evra birth control patch . In stark contrast, during a 6 year period between 1997 and September 2003, the Ortho birth control pill only generated 1,237 adverse event reports and 6 time more women were using the pill... - Guidant Settles Three Lawsuits - 549 To Go
Oct-2-06 Corpus Christi, TX Attorneys for the plaintiffs in lawsuits against Guidant and its new owner, Boston Scientific, view the settlement of a Texas case days before a jury trial as a sign that the company is dodging the courtroom. Guidant settled the case for an undisclosed amount with two plaintiffs avoiding a public trial set to begin on September 18, 20... - Uphill Battle - Warning Pharma Customers about Dangers of SSRIs
Sep-29-06 Recent concerns about the adverse effects of selective serotonin reuptake inhibitor antidepressants (SSRIs) have focused on suicide risks. However, a new study published in the September 2006 journal, Public Library of Science (PLoS), reports that in addition to self-harm, the drugs can also cause some patients to become violent and homicidal. Professor... - Zyprexa Sales Show No Amount of Lawsuits Will Deter Lilly
Sep-28-06 Indianapolis, IN Scores of new lawsuits are being filed by patients who say they took Zyprexa without knowing the risks after Eli Lilly promoted the drug to doctors as a treatment for conditions other than schizophrenia and bipolar disorder that the drug is approved to treat. In June 2005, Lilly announced plans to settle roughly 8,000 claims by pati... - FDA Still Dodging Bullets Over Ketek
Sep-27-06 Washington, DC: In recent months Senator Charles Grassley (R-IA) has been like a dog with a bone when it came to investigating why FDA officials approved the antibiotic Ketek , despite its knowledge that the main pre-approval study on the drug was riddled with fraud. Ketek first sought approval in 2000, but approval was denied due to indications of s... - Kaiser Kidney Transplant Program Gets Reprieve From Medicare Officials
Sep-25-06 San Francisco, CA In August 2006, Kaiser Permanente , the nation's largest Health Maintenance Organization, agreed to pay a $2 million fine and donate $3 million to a charity group after numerous government investigations determined that the HMO caused harm, and in some cases death, to hundreds of kidney transplant patients. Two months earlier in Ju... - Nursing Home Fraud, Neglect & Abuse Much Too Common
Sep-24-06 Highland Heights KY Residents in nursing homes are some of the most vulnerable and helpless citizens in the US, with nearly 1.7 million elderly and disabled persons residing in about 17,000 facilities. And as difficult as it is to believe in this day and age, there is indisputable evidence to show that many nursing home residents are being neglected... - Plavix Sales to Soar due to Faulty Heart Stents
Sep-22-06 Natick, MA Recent studies have shown the new generation of drug-eluting heart stents to be associated with an increased risk of late stent thrombosis, cardiac mortality, myocardial infarction, and all cause mortality. And at the same time, they have proven to be little more effective, if any, than the older bare-metal stents that sell for a fraction... - FDA Needs To Ban Accutane
Sep-20-06 Austin, TX: Unfortunately hundreds of parents already know that Accutane can cause some teenagers to commit suicide. But new evidence of a link between the acne drug and depression in the journal Neuropsychopharmacology , will hopefully put an end to the years of claims by Hoffman-LaRoche that its drug is not responsible for the suicides. Scien... - 500 Ortho Evra Birth Control Patch Victims Sue Johnson & Johnson
Sep-17-06 New Brunswick, NJ According to Johnson & Johnson's latest SEC filing for the Second Quarter of 2006, the company is currently facing 500 claimants in lawsuits related to deaths and injuries caused by the Ortho Evra birth control patch . "These claimants," the filing notes, "seek substantial compensatory and, where available, punitive damages. ... - Merck Insurance Carriers Jump Ship Over Vioxx Disaster
Sep-15-06 Whitehouse, NJ According to Merck's August 7, 2006, SEC filing, "At this time, the Company believes that its insurance coverage with respect to the Vioxx Lawsuits will not be adequate to cover its defense costs and any losses." In addition, Merck says it has not established any reserves for potential liability relating to the Vioxx lawsuits or inves... - Merck Vioxx Litigation Score Card
Sep-14-06 New Orleans, LA In the homestretch leading up to the latest trial in New Orleans, the score in the Vioxx litigation was 5 to 4 in favor of Merck. However, in mid-August, 2006, a New Jersey victory for Merck was thrown out reversing the score to 5 to 4 in favor of plaintiffs. But none of the winning plaintiffs should count their chickens before they... - Latest Pfizer Celebrex Court Ruling 50-50
Sep-11-06 San Francisco, CA According to Pfizer, Celebrex is still selling like hot cakes with worldwide sales totalling $471 million ($355 million in the US) in the second quarter of 2006, representing growth of 17% over the same period last year. "We continue to expect full-year Celebrex revenues of at least $2 billion, an ambitious target given the ongoing... - Johnson & Johnson Charite Spinal Disc Under Fire
Sep-7-06 Chicago, Illinois The Pulaski and Middleman law firm in Houston, Texas heads a group of law firms that represent over 350 injured Charite spinal disc recipients. The patients allege that the disc is defective, that the device was improperly marketed and that the company did not adequately warn of the disc's dangers. The Charite artificial disc was first... - Boston Scientific and Guidant Off to Texas Slaughterhouse
Sep-6-06 Corpus Christi, TX The first, but by no means the last, Guidant trial is scheduled to begin on September 18, 2006, in Neuces County District Court in Corpus Christi, Texas before Judge Jack Hunter. The two plaintiffs, Louis Motal, 63, and Bernice Hinojosa, 65, are surviving patients implanted with Guidant's Ventak Prizm 2 defibrillators in 2001. The law... - Pfizer Celebrex Lawsuits - 1500 and Counting
Sep-4-06 The first Celebrex trial, originally set for June 6, 2006, has been delayed indefinitely, reportedly to give attorneys more time to gather information. Although no new trial date has been set, legal analysts now predict that Celebrex trials will begin in early 2007. The delay was requested by a federal judge in San Francisco, where Pfizer is facing around... - Nursing Home Inspection Process Full Of Corruption
Sep-2-06 Nursing home companies invest heavily in local politicians. They do so to ensure the failure of efforts to pass legislation unfavorable to the industry and to buy protection against fines and penalties levied by state officials charged with investigating and monitoring the industry. According to a September 2006 report by Consumer Reports, "they wield con... - Roche puts Accutane profits over Lives of Consumers
Aug-31-06 In 1985, Accutane's package insert directed at doctors first mentioned reports of depression in patients taking the acne drug, which means that more than 20 years ago, Hoffman-LaRoche at least suspected there might be a risk of depression and suicide by persons taking the drug. However, Roche's financial records show that the company is not about to let a...